יחס שווי פעילות לרווח לפני ריבית, מסים ופחת Polyrizon Ltd. (PLRZ)

Polyrizon Ltd (PLRZ) is exposed to risks stemming from raw material logistics disruptions and export barriers, which complicate patent protection. The stock's price history visualizes the development of the Capture and Confine nasal barrier system, which creates a protective layer against allergens, while the EV/EBITDA ratio stands at 0.00. Business stability is ensured by a lean staff of biopolymer experts, eliminating the loss of key scientific knowledge.

This ratio determines the total enterprise value relative to its operating profit before depreciation, taxes, and interest. By analyzing the EV/EBITDA multiple over time, an investor assesses the company's resilience to debt loads and inflationary pressure on costs. For Polyrizon Ltd (PLRZ), this indicator is critically important as it reflects the capitalization efficiency of development costs for innovative barrier sprays.